Metagen Therapeutics is investigating the safety and efficacy of Antibiotic Fecal Microbiota Transplantation (A-FMT) in patients with advanced-stage Parkinson’s disease for microbiome therapeutics development. Learn more about the Yamagata-based organization in this installment of our Let’s Interview Series.
Venture Valuation (VV) interviewed Dr. NAKAHARA Taku, President and CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?